C-Path / Pfizer Inc. / Martha A. Brumfield LLC / /
Continent
Asia / / /
Event
Employment Change / /
Facility
Virginia Commonwealth University / Regulatory Harmonization Institute / American College of Surgeons / College of American Pathologists / Arizona State University / National Cancer Institute / ABOUT THE CRITICAL PATH INSTITUTE The Critical Path Institute / Critical Path Institute / University of Maryland / Rockefeller University / /
IndustryTerm
evaluation tools / pharmaceutical / regulatory systems / lifecycle pharmaceutical research / /
MedicalCondition
cancer / /
Organization
Harvard Medical School / National Cancer Institute / University of Maryland / College of American Pathologists / Virginia Commonwealth University / American Joint Committee on Cancer / Harvard Global Health Institute’s Multi-Regional Clinical Trial Center / Critical Path Institute / Regulatory Harmonization Institute / Data and Safety Monitoring Board / Commission on Cancer / Arizona State University / International office of Medicine / National Biomarkers Development Alliance / U.S. Food and Drug Administration / Rockefeller University / the American College / GlobalMD / /
Person
Peter B. Corr / Carolyn Compton / Martha Brumfield / Jeff Jacob / Martha A. Brumfield / Linda Welter Cohen / / /
Position
professor of Pathology / vice chairman / senior vice president of worldwide regulatory affairs and quality assurance / President / interim president and chief executive officer / director of International & Regulatory Programs / interim president and CEO / CEO / chairman / professor / chair / leader in biomarker development / international leader / vice chairman of board of directors / interim president and chief executive officer of the organization / chairman of board of directors / /
NEWS RELEASE FOR IMMEDIATE RELEASE Media Contact: Linda Welter Cohen [removed[removed]CRITICAL PATH INSTITUTE NAMES MARTHA BRUMFIELD CEO